09-10, 14:00–15:00 (Europe/Istanbul), Hearing Implant 2 (ICC - B3 Floor - 3B/70)
Panel presentation of long term results of implantable hearing aids
Mario E. Zernotti is professor of ENT at Catholic University of Córdoba and National University of Villa Maria, and also professor of Clinics of Hearing at National University of Córdoba. He has more than 30 years of experience in the field of ear surgery in Sanatorium Allende. He was the pioneer in electro acoustic stimulation (EAS) and hearing preservation in all America, doing the first cases of EAS cochlear implants in the continent. Besides, his team was the first to did Active Middle Ear Implants and bone conductive prosthesis in the region. This group is working specially in atresia/microtia patients, very common malformation in South-America, and northwest of Argentina, doing a comprehensive approach to the problem. Member of Hearring, Past president of GCIAN (Global Cochlear Implant Access Network) and President of the 8th World Congress on CI in Emerging Nations (2024).
- Cochlear Implantation: Surgical Concept, Special Cases, Precision Surgery, Tricks And Pitfalls
- Symposium Of The Society Of Polish Otorhinolaryngologists, Phoniatrists, And Audiologists
- New Paradigm In The Management Of Microtia - Aural Atresia
- Electrode Choice In CI
- Cochlear Ossification
- Bone Conduction Devices
Prof. Abdullah Dalgic is the Founding Chair and Clinical Director of the Department of Otorhinolaryngology – Head and Neck Surgery,
Director of the Cochlear Implant Center at Izmir City Hospital.
He was appointed full Professor of Otorhinolaryngology after completing his medical and residency training, along with an M.Sc. in Audiology and Speech Disorders at Ege University.
Prof. Dalgic serves in key leadership roles, including:
General Secretary, Turkish Society of Otology and Neurotology
Board Member, Turkish Otorhinolaryngology – Head and Neck Surgery Society
Vice President, Aegean ENT-HNS Association
His main clinical focus encompasses otology, neurotology, endoscopic ear surgery, cochlear implantation, audiology, facial plastic surgery, and head and neck oncology. He has published over 60 articles in international peer-reviewed journals.
Dr. Chen-Chi Wu is an attending physician at the Department of Otolaryngology, National Taiwan University Hospital (NTUH) and a professor at the National Taiwan University College of Medicine. He is currently the director of the Cochlear Implantation Program at NTUH and the vice superintendent of NTUH Hsin-Chu Branch.
Dr. Wu received a MD degree (1999), a PhD degree in medicine (2010), and a PhD degree in law (2020) from NTU. He holds both physician and attorney licenses in Taiwan. His clinical interest lies in pediatric otology, cochlear implantation, endoscopic ear surgery, and lateral skull base surgery. His research interest centers on molecular diagnostics and therapeutics of inner ear diseases. His team has been dedicated to the early detection, diagnosis, and management of childhood hearing impairment over the past 20 years.
Dr. Wu has been extensively involved in numerous international scientific societies. He is currently the president of Taiwan Academy of Otology, and is a board member of the Asia Pacific Symposium on Cochlear Implant and Related Sciences (APSCI) and a board member of East Asia Symposium on Otology (EASO). He is also an active member of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNSF), the Association for Research in Otolaryngology (ARO), the American Society of Human Genetics (ASHG), the Barany Society, the International Otopathology Society, and the Politzer Society. Dr. Wu was elected to the prestigious Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum (CORLAS) in 2022.
- Genetic Treatment Strategies For Hearing Loss
- CI In Meniere's Disease
- APSCI Board Panel
- Genetic Screening For Sensorineural Hearing Loss: When And To Whom
- TEMPORAL BONE DISSECTION: 1. Mastoidectomy (EAG)- 2. Endolymphatic Suc Surgery (JK)- Posterior Tympanotomy and CI (CCW)- Facial Nerve Decompression (KSO)
Sébastien Schmerber, MD, PhD, is a leading otologic surgeon and researcher at the University Hospital Grenoble Alpes (France), where he has served as Chair of the Department of Oto-Rhino-Laryngology & Head and Neck Surgery since 2018. Renowned for his pioneering work in hearing implants and auditory neuroscience, he was appointed Full Professor in 2005.
Professor Schmerber’s expertise is anchored in high-level international collaboration. From 2002 to 2003, he completed a postdoctoral fellowship at the University of Tokyo (Tōdai) Graduate School of Medicine. During this period, he trained under the supervision of Professor Kimitaka Kaga, a world-renowned authority in auditory neuroscience and cochlear implantation. A trailblazer in middle-ear and bone-conduction technology, Professor Schmerber performed France’s first Bonebridge implantation in 2014 and possesses nearly three decades of experience with Vibrant Soundbridge systems. He continues to push the boundaries of surgical precision through robotics: In December 2024, his department performed France’s first cochlear implantation using the OTODRIVE robot (MED-EL, Innsbruck, Austria). He maintains a close collaboration with Zentact Robotics (Grenoble, France) to develop a next-generation robot specifically designed for oto-endoscopic ear surgery. His research spans surgical innovation to advanced neuro-monitoring. A key achievement is the development of "Cochlear-Print," a patented sampling tool designed to study perilymph in partnership with industry leaders. This technology paves the way for future robotic fluid collection during implantation procedures. For over 25 years, Clinical Vestibular Research has been a core pillar of his department. Notably, the faculty pioneered a novel objective tool for multi-frequency vestibular assessment, utilizing skull vibrations to provide more accurate diagnostic data.